[ad_1] Sun Pharmaceutical Industries is likely to attract attention on Monday (November 4) following a recent US court ruling that has delayed the launch of its new drug, LEQSELVITM (deuruxolitinib). The US District Court of New Jersey issued a preliminary injunction, which blocks Sun Pharma from introducing the medication, intended for treating severe alopecia areata, […]